Logo image of MDXH.BR

MDxHealth SA (MDXH.BR) Stock Price, Quote, News and Overview

EBR:MDXH - Euronext Brussels - BE0974461940 - Common Stock - Currency: EUR

3.02  -0.12 (-3.76%)

MDXH.BR Quote, Performance and Key Statistics

MDxHealth SA

EBR:MDXH (12/15/2023, 7:00:00 PM)

3.02

-0.12 (-3.76%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High3.28
52 Week Low0.2
Market Cap82.41M
Shares27.29M
Float26.57M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-26 2006-06-26


MDXH.BR short term performance overview.The bars show the price performance of MDXH.BR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 200 400 600 800

MDXH.BR long term performance overview.The bars show the price performance of MDXH.BR in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300

The current stock price of MDXH.BR is 3.02 EUR. In the past month the price increased by 5.19%. In the past year, price increased by 381.66%.

MDxHealth SA / MDXH Daily stock chart

MDXH.BR Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 19.07 305.33B
1ABBV.MI ABBVIE INC 18.36 294.00B
AMG.DE AMGEN INC 13.41 131.91B
1GILD.MI GILEAD SCIENCES INC 13.7 116.36B
VX1.DE VERTEX PHARMACEUTICALS INC 1709.42 114.26B
GIS.DE GILEAD SCIENCES INC 13.22 112.29B
ARGX.BR ARGENX SE 378.56 35.37B
22UA.DE BIONTECH SE-ADR N/A 21.35B
IDP.DE BIOGEN INC 7.73 15.80B
1MRNA.MI MODERNA INC N/A 9.49B
0QF.DE MODERNA INC N/A 9.43B
BIO.DE BIOTEST AG 64.92 1.67B

About MDXH.BR

Company Profile

MDXH logo image MDxHealth SA is a BE-based company operating in Biotechnology industry. The company is headquartered in Herstal, Liege and currently employs 258 full-time employees. The company went IPO on 2006-06-26. MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Company Info

MDxHealth SA

CAP Business Center, Rue d'Abhooz 31

Herstal LIEGE BE

Employees: 258

MDXH Company Website

Phone: 3243642070

MDxHealth SA / MDXH.BR FAQ

What is the stock price of MDxHealth SA today?

The current stock price of MDXH.BR is 3.02 EUR. The price decreased by -3.76% in the last trading session.


What is the ticker symbol for MDxHealth SA stock?

The exchange symbol of MDxHealth SA is MDXH and it is listed on the Euronext Brussels exchange.


On which exchange is MDXH.BR stock listed?

MDXH.BR stock is listed on the Euronext Brussels exchange.


What is the price forecast or stock price prediction for MDxHealth SA stock?

9 analysts have analysed MDXH.BR and the average price target is 8.4 EUR. This implies a price increase of 178.05% is expected in the next year compared to the current price of 3.02. Check the MDxHealth SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MDxHealth SA worth?

MDxHealth SA (MDXH.BR) has a market capitalization of 82.41M EUR. This makes MDXH.BR a Micro Cap stock.


How many employees does MDxHealth SA have?

MDxHealth SA (MDXH.BR) currently has 258 employees.


What are the support and resistance levels for MDxHealth SA (MDXH.BR) stock?

MDxHealth SA (MDXH.BR) has a support level at 2.82. Check the full technical report for a detailed analysis of MDXH.BR support and resistance levels.


Is MDxHealth SA (MDXH.BR) expected to grow?

The Revenue of MDxHealth SA (MDXH.BR) is expected to grow by 84.81% in the next year. Check the estimates tab for more information on the MDXH.BR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MDxHealth SA (MDXH.BR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MDxHealth SA (MDXH.BR) stock pay dividends?

MDXH.BR does not pay a dividend.


What is the Price/Earnings (PE) ratio of MDxHealth SA (MDXH.BR)?

MDxHealth SA (MDXH.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.68).


MDXH.BR Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to MDXH.BR. When comparing the yearly performance of all stocks, MDXH.BR is one of the better performing stocks in the market, outperforming 99.77% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MDXH.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MDXH.BR. Both the profitability and financial health of MDXH.BR have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MDXH.BR Financial Highlights

Over the last trailing twelve months MDXH.BR reported a non-GAAP Earnings per Share(EPS) of -1.68. The EPS decreased by -16.81% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -51.61%
ROE -393.48%
Debt/Equity 2.17
Chartmill High Growth Momentum
EPS Q2Q%-700%
Sales Q2Q%73.48%
EPS 1Y (TTM)-16.81%
Revenue 1Y (TTM)66.59%

MDXH.BR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to MDXH.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of -6519.8% and a revenue growth 84.81% for MDXH.BR


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts86.67
Price Target8.4 (178.15%)
EPS Next Y-6519.8%
Revenue Next Year84.81%